Neogen Chemicals Limited (NEOGEN) — FY26 Annual Report | 26 July 2026

· NSE 🔴 High Importance Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
📢 Key Event
Q1 FY27 consolidated revenue up 34% YoY to INR 250.3 crore, PAT up 62% to INR 17.1 crore
🔄 What Changed
Revenue growth of 34% YoY and PAT growth of 62% YoY; EBITDA margin expansion of 260 bps to 19.3%; fund raise of up to INR 600 crore approved
🔮 What's Next
Commissioning of 1,000 MT lithium electrolyte capacity by H2 FY27; Dahej plant reconstruction complete with commercial production soon; total project cost of INR 1,795 crore for battery materials projects
💡 Investor Takeaway
Strong volume growth and margin expansion despite operational headwinds position Neogen well for battery materials expansion and government PLI incentives.

Neogen Chemicals reported Q1 FY27 consolidated revenue of INR 250.3 crore, up 34% YoY, driven by strong volume growth in Organolithium and Battery Chemicals despite Dahej plant shutdown and higher input costs. PAT rose 62% to INR 17.1 crore, with margins expanding to 6.8%. The company secured INR 600 crore fund raise approval and advanced its battery materials expansion, commissioning 200 MT of electrolyte capacity and securing provisional approvals from four international customers. Management highlighted robust execution of CAPEX plans and favorable government PLI incentives for battery localization.

📄 View Original Announcement (PDF)

About Neogen Chemicals Limited (NEOGEN)

Chemicals · Chemicals & Petrochemicals · Listed on NSE

Market Cap: ₹4,392.02 Cr P/E: 88.9

View full NEOGEN stock details →

📡 Get AI alerts when NEOGEN files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track NEOGEN — Free

📊 More NEOGEN filings

See all NEOGEN filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when NEOGEN files new disclosures

Track NEOGEN filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track NEOGEN — Free

Free account · 2 AI queries/day